NYSE: HBIHanesbrands Inc Stock
$6.39+0.04 (+0.63%)
Updated Nov 7, 2025
HBI Price
$6.39
Fair Value Price
N/A
Market Cap
$2.26B
52 Week Low
$3.96
52 Week High
$9.10
P/E
6.95x
P/B
5.06x
P/S
0.68x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.44B
Earnings
$330.01M
Gross Margin
42%
Operating Margin
9.26%
Profit Margin
9.6%
Debt to Equity
8.58
Operating Cash Flow
$23M
Beta
1.26
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HBI Overview
Hanesbrands Inc. sells men's underwear, women's panties, children's underwear, activewear, and socks, as well as intimate apparel, under the Hanes, Champion, Playtex, Bali, L'eggs, Just My Size, Barely There, Wonderbra, Maidenform, Berlei, and Bonds brand names. Hanesbrands distributes products in the U.S. and internationally. The company was founded in 1901 and is based in Winston-Salem, NC.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HBI's potential to beat the market
- HBI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Apparel Manufacturing
Industry Rating
B
HBI
RankedUnranked of 17
RankedUnranked of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.55 | A | |
| $324.68 | B | |
| $72.18 | B |
Be the first to know about important HBI news, forecast changes, insider trades & much more!
HBI News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HBI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HBI is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HBI is good value based on its earnings relative to its share price (6.95x), compared to the US market average (44.8x)
P/E vs Market Valuation
HBI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more HBI due diligence checks available for Premium users.
Valuation
HBI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.95x
Industry
22.1x
Market
44.8x
HBI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HBI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
HBI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.06x
Industry
2.94x
HBI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HBI's financial health
Profit margin
Revenue
$891.7M
Net Income
$270.7M
Profit Margin
30.4%
HBI's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
HBI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.3B
Liabilities
$3.8B
Debt to equity
8.58
HBI's short-term assets ($1.88B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HBI's long-term liabilities ($2.59B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HBI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HBI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$27.6M
Investing
-$3.9M
Financing
-$26.8M
HBI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HBI vs Apparel Manufacturing Stocks
Hanesbrands Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.